John Latham
Consultant / Advisor at Accelerator Services Corp
John Latham active positions
| Companies | Position | Start | End |
|---|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - | - |
Career history of John Latham
Former positions of John Latham
| Companies | Position | Start | End |
|---|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2003-12-31 | 2019-04-04 |
| Founder | 2003-12-31 | 2019-04-04 | |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | 1997-12-31 | 2003-12-31 |
Darwin Molecular Corp
 Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Corporate Officer/Principal | 1993-12-31 | 1997-12-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 1988-12-31 | 1993-12-31 |
Training of John Latham
| Massachusetts Institute of Technology | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
Statistics
International
| United States | 7 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Darwin Molecular Corp
Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Commercial Services |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
- Stock Market
- Insiders
- John Latham
- Experience
